Alzheimer’s disease drugs can lower macular degeneration risk
By
Kristen Fischer
Jan 08, 2024
Ccetylcholinesterase inhibitors (AChEIs) used to treat Alzheimer’s disease may lower the risk for developing age-related macular degeneration (AMD), according to a study published last week in JAMA Ophthalmology.
Rural assisted living residents with dementia half as likely to take cognition enhancing meds
By
Alicia Lasek
Feb 03, 2021
A new study in Oregon assisted living and residential care communities sheds light on medication trends in these settings, including a notable quirk in rural care.
Popular Alzheimer’s drug raises risk of hospitalization for painful condition
By
Alicia Lasek
Sep 16, 2019
Donepezil, also known as Aricept, appears to double the risk of hospitalization for a painful muscle condition, according to a new study.
More than 50% of dementia patients in nursing homes are given potentially pointless and dangerous drugs...
By
Tim Mullaney
Sep 10, 2014
Nursing homes administer largely pointless and potentially harmful drugs to a majority of residents with advanced dementia, according to findings in Jama Internal Medicine.
Doctors warn against Aricept for dementia care, supplements for weight control in second annual ‘Choosing...
By
Tim Mullaney
Feb 28, 2014
Clinicians should prescribe cholinesterase inhibitors very cautiously and suspend use if dementia symptoms aren’t reduced within 12 weeks, according to new “Choosing Wisely” recommendations...
Early dementia screening is accurate but pointless, researchers find
By
Tim Mullaney
Oct 23, 2013
Assessment tools can effectively identify people in the early stages of dementia, but existing evidence suggests there is no pressing reason to do this type of cognitive screening, according to newly published...
Pain management difficult for stoic residents, those with dementia, study finds
By
Tim Mullaney
Sep 18, 2013
Effective pain management in long-term care is hampered by residents’ attitudes and caregivers’ misinterpretation of behaviors, according to newly published research in the journal Nursing...
Is the National Football League our best hope for Alzheimer’s progress?
By
John O'Connor
Feb 04, 2013
More than 110 million Americans watched yesterday’s Super Bowl in New Orleans. It’s not too hard to see why the game has become our nation’s defining cultural ritual. The National Football...
Higher dose of Alzheimer’s drug approved despite FDA warnings, report shows
By
McKnight's Staff
Mar 26, 2012
Makers of the Alzheimer’s drug Aricept released a higher dosage version of the medication despite concerns about side effects and reduced efficacy, a study reports.
Expanded role for Alzheimer’s medications?
Mar 14, 2012
Aricept and Namenda are typically used in the treatment of early-stage Alzheimer’s disease. They might also be helpful as the disease progresses, according to British investigators. Researchers found...